Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-ATAZANAVIR DIN 02479249

Status: Approved
Holder: APOTEX INC
Molecule: ATAZANAVIR (ATAZANAVIR SULFATE)

Health Canada record

Active ingredient(s)ATAZANAVIR (ATAZANAVIR SULFATE) 150 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ05AE08 ATAZANAVIR
Original market date
Current status date23-Jul-2018
SourceHealth Canada DPD

Establishment licence of the holder

Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ATAZANAVIR (ATAZANAVIR SULFATE)

DINProductCompanyFormStrengthStatus
02479257APO-ATAZANAVIRAPOTEX INCCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 200 MGApproved
02479265APO-ATAZANAVIRAPOTEX INCCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 300 MGApproved
02456885MYLAN-ATAZANAVIRMYLAN PHARMACEUTICALS ULCCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 200 MGMarketed
02456893MYLAN-ATAZANAVIRMYLAN PHARMACEUTICALS ULCCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 300 MGMarketed
02456877MYLAN-ATAZANAVIRMYLAN PHARMACEUTICALS ULCCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 150 MGMarketed
02443813TEVA-ATAZANAVIRTEVA CANADA LIMITEDCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 200 MGMarketed
02443821TEVA-ATAZANAVIRTEVA CANADA LIMITEDCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 300 MGMarketed
02443791TEVA-ATAZANAVIRTEVA CANADA LIMITEDCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 150 MGMarketed
02446731EVOTAZBRISTOL-MYERS SQUIBB CANADATabletATAZANAVIR (ATAZANAVIR SULFATE) 300 MG; COBICISTAT 150 MGCancelled Post Market
02513129JAMP ATAZANAVIRJAMP PHARMA CORPORATIONCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 300 MGDormant
02513102JAMP ATAZANAVIRJAMP PHARMA CORPORATIONCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 150 MGDormant
02513110JAMP ATAZANAVIRJAMP PHARMA CORPORATIONCapsuleATAZANAVIR (ATAZANAVIR SULFATE) 200 MGDormant
02248610REYATAZBRISTOL-MYERS SQUIBB CANADACapsuleATAZANAVIR (ATAZANAVIR SULFATE) 150 MGCancelled Post Market
02248609REYATAZBRISTOL-MYERS SQUIBB CANADACapsuleATAZANAVIR (ATAZANAVIR SULFATE) 100 MGCancelled Pre Market
02294176REYATAZBRISTOL-MYERS SQUIBB CANADACapsuleATAZANAVIR (ATAZANAVIR SULFATE) 300 MGCancelled Post Market
02248611REYATAZBRISTOL-MYERS SQUIBB CANADACapsuleATAZANAVIR (ATAZANAVIR SULFATE) 200 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
211232018-07-23Abbreviated New Drug Submission (ANDS)
Request a quote for APO-ATAZANAVIR

How to read a Canadian DIN record